Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gynecologic Oncology
•
Gastrointestinal Cancers
•
General Internal Medicine
How do you manage urgency and frequency of bowel movements secondary to radiation proctitis?
Answer from: Radiation Oncologist at Community Practice
In the acute setting we try anusol HC suppository to decrease tenesmus like symptoms
Comments
Radiation Oncologist at Fox Chase Cancer Center
I agree. There’s not a lot of data here, but we ...
609
Sign in or Register to read more
3402
Related Questions
How do you manage persistent rectal bleeding in the setting of rectal adenocarcinoma in a treatment-naive patient?
Would you change treatment approach for rectal cancer with an associated intussusception?
Which patients, if any, treated according to PROSPECT for an early stage rectal cancer, would you offer surveillance if they achieved cCR after neoadjuvant chemotherapy?
How would you plan a post-op, distal rectal adenocarcinoma s/p neo-adjuvant chemotherapy and APR with minimal treatment response?
When treating pancreatic body/tail lesions that result in significant dose spread to the spleen, what is your threshold to offer pneumococcal, hemophilus influenza, and meningococcal vaccines?
Would you use triplet chemotherapy FLOT in lieu of chemoRT for patients with localized esophageal squamous cell carcinoma?
In a patient with metastatic colorectal cancer to the lung and liver, is there a role for liver directed therapy if the lung is not amenable to local therapy?
What are your top takeaways from SGO 2025?
Given the results of PLATO anal cancer study, is 4140 cGy the new standard for early stage anal cancer?
For vaginal cuff recurrence of an endometrial cancer, when do you utilize a multichannel cylinder versus single channel cylinder if a patient has <5 mm residual disease after EBRT?
I agree. There’s not a lot of data here, but we ...